Key Points
- CEO R. Allison sold 98,958 shares for about $12.2 million, reducing his stake by 35.08%; he retained 183,150 shares after the transaction.
- Addus HomeCare reported quarterly EPS of $1.83, beating the $1.79 consensus, while revenue of $387.74 million came in slightly below expectations and rose 7% year over year.
- Analysts hold a consensus “Moderate Buy” rating with an average price target of $134.70; seven rate the stock Buy, four Hold, and one Sell.
Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP Cliff Donald Blessing sold 2,000 shares of the firm's stock in a transaction on Friday, November 6th. The stock was sold at an average price of $124.18, for a total value of $248,360.00. Following the completion of the sale, the executive vice president directly owned 10,183 shares of the company's stock, valued at $1,264,524.94. The trade was a 16.42% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Addus HomeCare Trading Up 3.2%
Shares of NASDAQ:ADUS opened at $126.29 on Wednesday. The business's 50-day moving average is $117.97 and its 200 day moving average is $107.02. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $131.59. The firm has a market capitalization of $2.35 billion, a P/E ratio of 21.05, a P/E/G ratio of 1.62 and a beta of 0.75. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, beating analysts' consensus estimates of $1.79 by $0.04. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The company had revenue of $387.74 million during the quarter, compared to analysts' expectations of $388.72 million. During the same period last year, the business posted $1.56 earnings per share. The firm's revenue was up 7.0% compared to the same quarter last year. On average, research analysts predict that Addus HomeCare Corporation will post 6.36 earnings per share for the current fiscal year.
Analysts Set New Price Targets
ADUS has been the topic of several recent analyst reports. TD Cowen upped their price objective on shares of Addus HomeCare from $131.00 to $145.00 and gave the company a "buy" rating in a report on Thursday, November 5th. Raymond James Financial set a $137.00 target price on shares of Addus HomeCare in a research note on Monday, September 28th. Wall Street Zen upgraded shares of Addus HomeCare from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Citigroup downgraded shares of Addus HomeCare from a "market outperform" rating to a "neutral" rating in a research report on Monday, September 14th. Finally, Weiss Ratings upgraded shares of Addus HomeCare from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, September 24th. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Addus HomeCare presently has a consensus rating of "Moderate Buy" and an average price target of $134.70.
Read Our Latest Report on Addus HomeCare
Institutional Trading of Addus HomeCare
Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Addus HomeCare in the second quarter valued at about $344,153,000. Dimensional Fund Advisors LP raised its stake in shares of Addus HomeCare by 11.8% in the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company's stock worth $69,689,000 after purchasing an additional 78,415 shares during the last quarter. Bank of America Corp DE purchased a new position in shares of Addus HomeCare in the second quarter worth about $35,527,000. Boston Partners lifted its holdings in shares of Addus HomeCare by 18.0% during the third quarter. Boston Partners now owns 290,332 shares of the company's stock worth $32,222,000 after purchasing an additional 44,279 shares during the period. Finally, TimesSquare Capital Management LLC acquired a new stake in shares of Addus HomeCare during the second quarter worth about $31,502,000. Hedge funds and other institutional investors own 95.35% of the company's stock.
Key Stories Impacting Addus HomeCare
Here are the key news stories impacting Addus HomeCare this week:
- Neutral Sentiment: Addus said it will participate in the 2026 Stephens Annual Investment Conference. The announcement provides an opportunity to meet investors but gives no new financial or operating guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
- Neutral Sentiment: A report listed short interest at zero shares, indicating no reported short position; however, its description of a “large increase” conflicts with that figure.
- Negative Sentiment: Several executives disclosed stock sales. CEO R. Allison sold 98,958 shares for about $12.2 million, reducing his holding by 35.08%. Five EVPs collectively sold 32,697 shares for roughly $4.1 million. Insider sales can weigh on sentiment, although they do not by themselves establish a negative outlook. CEO sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
